{
    "nctId": "NCT04650256",
    "briefTitle": "Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences",
    "officialTitle": "Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences",
    "overallStatus": "RECRUITING",
    "conditions": "Skin Toxicity",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Proportion of patients free of clinically relevant skin toxicities",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female subjects with newly diagnosed breast carcinoma\n* \\> 18 years of age\n* Post-mastectomy with or without reconstruction\n* Stage II-IIIb with any receptor status\n* All races and ethnicities are eligible\n* Patients must be able to consent in English or Spanish\n* Plan to receive adjuvant radiotherapy to the chest wall +/- regional lymph nodes\n* RT will involve standard fractionation use of 3D conformal or Intensity-modulated RT (IMRT)\n* Willing to sign protocol consent form\n* Patients are allowed to receive adjuvant hormonal therapy and/or targeted therapies such as trastuzumab prior to, during and/or after radiation therapy.\n* Patients may receive chemotherapy before or after radiation therapy\n\nExclusion Criteria:\n\n* Prior radiation to the involved breast or chest wall\n* Concurrent chemotherapy\n* Unable or unwilling to sign informed consent\n* Unable to speak English or Spanish\n* Pregnant women\n* Clinical or pathologic stage T4\n* Metastatic disease\n* Connective tissue disorder including Systemic Lupus Erythematosus and Scleroderma",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}